Abatacept may drive earlier, a sustained response in lupus nephritis

The selective T cell costimulation modulator abatacept can lead to a rapid improvement in proteinuria, which induces earlier, sustained complete response compared with placebo in patients with active class III or IV lupus nephritis, although the rate of complete response is similar between groups, suggests a study.